Editorial: Aminosalicylates in Crohn's Disease-Prevalence, Risks, Costs and Time to Reassess? Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14908
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley